Article Details

Eli Lilly hands Kumquat Biosciences $70M to kick off cancer drug R&D alliance

Retrieved on: 2021-07-29 14:28:27

Tags for this article:

Click the tags to see associated articles and topics

Eli Lilly hands Kumquat Biosciences $70M to kick off cancer drug R&D alliance. View article details on hiswai:

Excerpt

The company has raised more than $100 million in financing from OrbiMed, Sequoia Capital China, EcoR1, Lilly Asia Ventures, and Roche Venture ...

Article found on: medcitynews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up